Quibble Genomics offers several types of genetic services, customized to meet your specific needs and interests
A basic genome, or genotype, shows known bio-markers or variants in your DNA. Having bio-markers for a genetic health condition does not necessarily predict a health issue, The app shows only the most prevalent and rare conditions the individual genome is at risk for according to the population at large while recommending free and local clinical trials that are available for immediate enrollment through a healthcare provider.
A Clinical Genome gives the best of both from basic and whole genomes while clinically usable. Since an exome only includes coding regions in the DNA, it is more compact than a whole genome and as such it costs less than a clinical whole genome sequencing. This is recommended for clinical DNA profiling and it often serves as the primary basis for ordering panel tests to confirm genetic pre-dispositions for health conditions.
A Whole Genome captures your complete DNA, including the bio-markers found in a Basic Genome, as well as parts of the DNA that the field of science has not determined an exact purpose for yet. With a Whole Genome you will never need to have your DNA sequenced again; it will always be up to date as new genetic discoveries are made.
Thousands of health conditions have been discovered to have a genetic basis and many can be confirmed using bioinformatic analysis on multiple related genes. Test panels are offered that analyze multiple genes for multiple related health conditions. These panels can be ordered to clinically confirm the genetic predispositions.
D-Code™ (an existing 23andMe or Ancestry.com or any other source genome for $50 - SPECIAL)
D-Code is a way for you to prioritize which of the tens of conditions your genome might be susceptible to using population health metrics. Quibble generates a visual percentile report (Donut chart or a word forest) highlighting the most prevalent conditions your genome is at risk for along with available local and free clinical trials that you could take advantage of. Currently, genomes from 23&me and ancestry.com are supported